Back to Search
CARLEY DRYE BLOOMFIELD DO
DO
Internal Medicine Physician
NPI: 1386200962Individual
Specialties, Licenses & Credentials
Hospice and Palliative Medicine (Internal Medicine) Physician
Internal Medicine — Hospice and Palliative Medicine
Code: 207RH0002X
2023-01719(NC)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2023-01719(NC)
Research & Publications (20)
Cancer and leukemia group B leukemia correlative science committee: major accomplishments and future directions.
PMID 16740786·Clin Cancer Res·2006
6-review
11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
PMID 11921271·Genes Chromosomes Cancer·2002
4-observational
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
PMID 19451432·J Clin Oncol·2009
8-other
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
PMID 19025972·Cancer·2009
3-trial
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
PMID 19357394·Blood·2009
6-review
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
PMID 19211935·Blood·2009
8-other
Acquired copy number alterations in adult acute myeloid leukemia genomes.
PMID 19651600·Proc Natl Acad Sci U S A·2009
8-other
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.
PMID 18670778·Cancer Chemother Pharmacol·2009
3-trial
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
PMID 18591543·J Clin Oncol·2008
3-trial
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.
PMID 18559876·J Clin Oncol·2008
2-rct
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
PMID 18502832·Blood·2008
3-trial
Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats.
PMID 18512213·Synapse·2008
7-preclinical
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
PMID 17940205·Blood·2008
8-other
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.
PMID 18566324·Blood·2008
8-other
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
PMID 18450603·N Engl J Med·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 6 locations total
- Address
- 1000 BLYTHE BLVD
CHARLOTTE, NC 28203 - Phone
- (704) 351-3791
Locations (6)
Practice Location
1000 BLYTHE BLVD, CHARLOTTE, NC
(704) 351-3791
Practice Location
2001 VAIL AVE, CHARLOTTE, NC
(704) 607-3249
Practice Location
10628 PARK RD, CHARLOTTE, NC
(704) 351-9422
Practice Location
8800 N TRYON ST, CHARLOTTE, NC
(704) 351-0478
HOSPICE OF THE PIEDMONT, INC.
1801 WESTCHESTER DR, HIGH POINT, NC
(336) 889-8446
Practice Location
433 MCALISTER RD, LINCOLNTON, NC
(704) 574-4746
Quick Facts
- NPI
- 1386200962
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile